HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Ohtani Selected Research

vanitaracin A

12/2015A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoko Ohtani Research Topics

Disease

18Neoplasms (Cancer)
05/2022 - 02/2005
4Inflammation (Inflammations)
04/2022 - 05/2013
4Carcinogenesis
02/2022 - 11/2010
4Obesity
01/2022 - 07/2013
4Infections
01/2019 - 12/2015
3Retinoblastoma (Glioblastoma, Retinal)
11/2006 - 07/2003
2Fibrosis (Cirrhosis)
05/2022 - 04/2019
2Bites and Stings (Sting)
04/2022 - 01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2022
1Pancreatitis
05/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Hepatic Encephalopathy
01/2022
1Fatty Liver
02/2021
1Liver Neoplasms (Liver Cancer)
02/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Virus Diseases (Viral Diseases)
01/2019
1Non-alcoholic Fatty Liver Disease
01/2017
1Reinfection
12/2015
1Hepatitis B
12/2015
1Metabolic Diseases (Metabolic Disease)
11/2015
1Wounds and Injuries (Trauma)
12/2014
1Lung Neoplasms (Lung Cancer)
08/2013
1Adenocarcinoma of Lung
08/2013
1Fever (Fevers)
07/2012
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
07/2012
1Nephrotic Syndrome (Syndrome, Nephrotic)
07/2012
1Warts (Wart)
11/2006

Drug/Important Bio-Agent (IBA)

5Cyclin-Dependent Kinase Inhibitor p16IBA
04/2015 - 11/2006
3InterferonsIBA
04/2022 - 01/2018
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022 - 08/2004
3Proteins (Proteins, Gene)FDA Link
07/2014 - 02/2005
2anthraceneIBA
05/2022 - 11/2010
2CytokinesIBA
04/2022 - 05/2013
2ChemokinesIBA
04/2022 - 05/2013
2DNA (Deoxyribonucleic Acid)IBA
04/2022 - 01/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2022 - 05/2013
2Biological ProductsIBA
01/2022 - 01/2017
2LipidsIBA
02/2021 - 12/2018
2Deoxycholic Acid (Sodium Deoxycholate)IBA
01/2017 - 07/2013
2Pharmaceutical PreparationsIBA
12/2015 - 08/2013
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
08/2004 - 07/2003
1CytoglobinIBA
05/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022
1AntioxidantsIBA
05/2022
1Cysteine (L-Cysteine)FDA Link
05/2022
1Glutathione (Reduced Glutathione)IBA
05/2022
1Hemeproteins (Heme Protein)IBA
05/2022
1cyclic guanosine monophosphate-adenosine monophosphateIBA
04/2022
1Interleukin-33IBA
01/2022
1Rifaximin (L 105)FDA Link
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1SenotherapeuticsIBA
01/2022
1Volatile Fatty AcidsIBA
11/2021
1Dietary FiberFDA Link
11/2021
1Butyrates (Butyrate)IBA
01/2021
1Peptides (Polypeptides)IBA
01/2019
1Epidermal Growth Factor (EGF)IBA
01/2019
1CoumarinsIBA
01/2018
1Dinoprostone (PGE2)FDA Link
01/2017
1Toll-Like Receptor 2IBA
01/2017
1lipoteichoic acidIBA
01/2017
1sodium-bile acid cotransporterIBA
12/2015
1vanitaracin AIBA
12/2015
1PolyketidesIBA
12/2015
1Antiviral Agents (Antivirals)IBA
12/2015
1Endocrine DisruptorsIBA
11/2015
1Platelet-Derived Growth FactorIBA
12/2014
1platelet-derived growth factor AIBA
12/2014
1A-Form DNA (A-DNA)IBA
04/2014
1Bile Acids and Salts (Bile Acids)IBA
04/2014
1ErbB Receptors (EGF Receptor)IBA
08/2013
1Tyrosine Kinase InhibitorsIBA
08/2013
1Gefitinib (Iressa)FDA Link
08/2013
1Pharmacologic ActionsIBA
08/2013
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2013
1Therapeutic UsesIBA
08/2013
1Losartan (Cozaar)FDA LinkGeneric
07/2012
1Dipyridamole (Persantine)FDA LinkGeneric
07/2012
1Warfarin (Coumadin)FDA LinkGeneric
07/2012
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2012
1SteroidsIBA
07/2012
1Rituximab (Mabthera)FDA Link
07/2012
1Acetates (Acetic Acid Esters)FDA Link
11/2010
1Phosphotransferases (Kinase)IBA
11/2006
1Oncogene Proteins (Oncogene Protein)IBA
07/2003

Therapy/Procedure

5Therapeutics
02/2022 - 07/2012